US Archives - Page 54 of 148 - European Medical Journal

ASCO 2025 Interview: Erika Hamilton

As practicing oncologists, we can get bogged down in our individual practices and thus have trouble seeing the bigger picture in…

New Biomarkers Strengthen McDonald Criteria for MS Diagnosis

Two promising biomarkers, the kappa free light chains (kFLC) index and central vein sign (CVS), have been incorporated into the revised 2024 McDonald criteria, offering improved diagnostic precision for multiple sclerosis (MS) and radiologically isolated syndrome (RIS).

New Tech Model Streamlines Lung Cancer Screening

A digital integration strategy significantly improved coordination and data collection across multiple lung cancer screening sites, according to a new study evaluating implementation within a large U.S. health system.

Warning Signs of Sudden Death in Epilepsy

EEG suppression after seizures may signal increased SUDEP risk in children with epilepsy, according to a new study evaluating clinical and electrophysiological indicators.

Less Invasive Option Rivals Needle Biopsy for Lung Nodules

Navigational bronchoscopy demonstrated noninferior diagnostic accuracy to transthoracic needle biopsy in evaluating peripheral pulmonary nodules, according to findings from a U.S.-based multicenter trial published June 2025.

Study Flags Autoimmune Concerns with GLP-1 Use

Patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may face an increased risk of developing certain autoimmune diseases compared with those on dipeptidyl peptidase-4 inhibitors (DPP-4is), according to new real-world evidence from a large U.S. cohort.

Sharp Rise in Syphilis Found in Türkiye HIV Study

Syphilis rates remain alarmingly high among people living with HIV in Türkiye, particularly in younger men, according to a new large-scale cross-sectional study analyzing national laboratory data.

Common Osteoarthritis Genes Not Linked to Progression

Genetic risk scores for knee osteoarthritis do not predict disease progression, new cohort study reveals.

Emerging Biologics in Treating Pemphigus and Bullous Pemphigoid

Emerging immunotherapies are transforming the treatment landscape for pemphigus and bullous pemphigoid, two distinct autoimmune blistering skin diseases marked by pathogenic autoantibodies and significant patient burden.

AI Image Analysis Predicts BRAF Mutation Status

A novel artificial intelligence pipeline can predict BRAF mutation status directly from histopathology slides, marking a potential step forward in digital dermatopathology and melanoma care.